Cargando…
Clinical Implications of Intestinal Barrier Damage in Psoriasis
BACKGROUND: An increasing amount of evidence suggests an association between increased intestinal permeability and the pathogenesis of chronic inflammatory diseases. However, the clinical significance of gut barrier dysfunction in psoriasis remains to be established. OBJECTIVE: To evaluate whether t...
Autores principales: | Sikora, Mariusz, Stec, Albert, Chrabaszcz, Magdalena, Giebultowicz, Joanna, Samborowska, Emilia, Jazwiec, Radoslaw, Dadlez, Michal, Olszewska, Malgorzata, Rudnicka, Lidia |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7851376/ https://www.ncbi.nlm.nih.gov/pubmed/33542642 http://dx.doi.org/10.2147/JIR.S292544 |
Ejemplares similares
-
Trimethylamine N-Oxide, a Gut Microbiota-Derived Metabolite, Is Associated with Cardiovascular Risk in Psoriasis: A Cross-Sectional Pilot Study
por: Sikora, Mariusz, et al.
Publicado: (2021) -
Intestinal Fatty Acid Binding Protein, a Biomarker of Intestinal Barrier, is Associated with Severity of Psoriasis
por: Sikora, Mariusz, et al.
Publicado: (2019) -
Gut Microbiome in Psoriasis: An Updated Review
por: Sikora, Mariusz, et al.
Publicado: (2020) -
The Clinical Significance of Serum Biomarkers of the Intestinal Barrier in Systemic Sclerosis: A Cross-Sectional Study
por: Stec, Albert, et al.
Publicado: (2023) -
The Gut Microbial Metabolite Trimethylamine N-Oxide is Linked to Specific Complications of Systemic Sclerosis
por: Stec, Albert, et al.
Publicado: (2023)